Arbutus Biopharma (0SGC.LSE) Q4 2025 Earnings

13NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.13
-0.08
-0.04
0.01

Details

Expected EPS
-0.03
Actual EPS
-0.04
Surprise EPS
-0.01
Surprise Percent
+33.33%

Description

Arbutus Biopharma (0SGC.LSE) has reported earnings of -0.04 per share for Q4 2025.

0 Comments

Share your thoughts